NCNA
NCNA clinical trials: NuCana plc
Every trial on ClinicalTrials.gov where NuCana plc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 7
- Trials linked
- 6
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
NCNA on the catalyst calendar · NCNA registry changes
- Primary completion Jul 2027Sponsor estimatePhase 1/Phase 2NCT03829254A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and LymphomaNuCana plc · Advanced CancerRecruitingNCNALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 30, 2025ActualPhase 1/Phase 2NCT05714553NUC-3373 in Combination With Other Agents in Patients With Advanced Solid TumoursNuCana plc · Advanced CancerTerminatedNCNALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 29, 2024ActualPhase 2NCT05678257A Study of NUC-3373 in Combination With Other Agents in Patients With Colorectal CancerNuCana plc · Colorectal CancerTerminatedNCNALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 19, 2024ActualPhase 1/Phase 2NCT03428958A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer TreatmentNuCana plc · Colorectal CancerCompletedNCNALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2, 2022ActualPhase 3NCT04163900Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract CancerNuCana plc · Biliary Tract CancerTerminatedNCNALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2019ActualPhase 2NCT03146663NUC-1031 in Patients With Platinum-Resistant Ovarian CancerNuCana plc · Ovarian CancerTerminatedNCNALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2015ActualPhase 1NCT01621854NUC-1031 in Patients With Advanced Solid TumoursImperial College London · CancerCompletedNCNACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 7 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner